Pharmafile Logo
Pharmafocus logo
Advanced Search

Eliquis

Showing 15 posts of 25 posts found.

Xarelto image

Bayer promotes Xarelto benefits

June 15, 2015
Sales and Marketing Bayer, Eliquis, Xarelto, blood, law suits, rivaroxaban

Bayer HealthCare is releasing new evidence to suggest that the risk of taking its best-selling blood thinner Xarelto is outweighed …

News
bayer_chimney

Bayer buys blood-thinning drug from Isis

May 5, 2015
Research and Development, Sales and Marketing Bayer, Eliquis, ISIS-FXI, Isis, Xarelto, blooding thinning

German drug giant Bayer is sealing a $155 million deal with Isis Pharmaceuticals to gain access to its anti-clotting treatment …

News
Bayer image

Profits fall at Bayer but new drugs see growth

May 1, 2015
Sales and Marketing Bayer, Eliquis, Eylea, Renegeron, Xarelto, apixaban

Bayer’s pharmaceutical revenues have continued their upward trajectory in the first quarter of 2015 thanks to new products, although this …

News
Eliquis image

Anti-blood clotting drug Eliquis gets NICE nod

March 6, 2015
Sales and Marketing BMS, DVT, Eliquis, NICE, Pfizer, Pradaxa, apixaban, clotting

Bristol-Myers Squibb and Pfizer’s Eliquis for preventing blood clots has been shown the green light to treat venous thromboembolism (VTE), …

News
Pfizer image

Pfizer posts fourth-quarter revenue decline

January 28, 2015
Sales and Marketing Eliquis, Lipitor, Lyrica (pregablin), Pfizer, Read, Xeljanz, apixaban, financials, pneumococcal vaccine Prevnar, q4, tofacitinib citrate

Pfizer posted a 3% decline in revenue in the last quarter of 2014, the company’s latest financial results show. The …

News
Boehringer image

Boehringer trials Pradaxa anti-bleeding antidote

December 11, 2014
Sales and Marketing BMS, Bayer, Boehringer, Eliquis, Pradaxa, ash, dabigatran, idarucizumab

Boehringer Ingelheim says that its investigational drug can safely reverse the blood-thinning effect of its anti-clotting drug Pradaxa (dabigatran). The …

News
eliquis image

Pfizer/BMS blood thinner gains new licence

August 22, 2014
Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin

Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …

News
Eliquis image

Eliquis poised for new US approval

July 12, 2013
Sales and Marketing BMS, Bayer, DVT, Eliquis, warfarin

Pfizer and Bristol-Myers Squibb have submitted their oral direct Factor Xa inhibitor Eliquis to the FDA to prevent deep vein …

News
eliquis image

VTE boost for Eliquis

July 2, 2013
Research and Development, Sales and Marketing AMPLIFY, BMS, DVT, Eliquis, Pfizer

Bristol-Myers Squibb and Pfizer’s oral blood thinner Eliquis is as efficient as standard of care and causes less bleeding in …

News
Eliquis image

Eliquis approved by NICE

February 28, 2013
Sales and Marketing BMS, Eliquis, NICE, Pfizer

In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …

News
Eliquis image

Eliquis in UK for AF

December 13, 2012
Sales and Marketing AF, BMS, Eliquis, NVAF, Pfizer

Eliquis has been made available in the UK today to prevent stroke and systemic embolism in patients with nonvalvular atrial …

News
Eliquis image

Further indications for Eliquis

November 22, 2012
Sales and Marketing BMS, Eliquis, NVAF, Pfizer, Pradaxa, Xarelto

Bristol-Myers Squibb and Pfizer’s oral blood-thinner Eliquis has been approved in Europe to prevent stroke in patients with nonvalvular atrial …

News
Xarelto image

Further US approval for Xarelto

November 5, 2012
Sales and Marketing Eliquis, FDA, Pradaxa, Xarelto

US regulators have given the go-ahead to expand the indications for which Janssen Pharmaceuticals and Bayer HealthCare’s oral blood thinner …

News
Eliquis image

Eliquis receives nod in AF

September 24, 2012
Sales and Marketing BMS, CHMP, Eliquis, Pfizer, Pradaxa, Xarelto

Bristol-Myers Squibb and Pfizer have received a boost with the CHMP’s recommendation that their co-marketed oral anticoagulant Eliquis should gain …

News
Xarelto image

Priority review for Xarelto’s new indications

July 10, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Eliquis, FDA, Janssen, Pradaxa, Xarelto

Xarelto is to be given a FDA fast-track review for a range of anti-blood clotting uses. Xarelto (rivaroxaban) gained its …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024